Reversible Posterior Leukoencephalopathy Syndrome

Abstract

Reversible posterior leukoencephalopathy syndrome is characterized clinically by headache, abnormalities of mental status and visual perception, and seizures. Despite its diverse causes, common precipitating factors are defined as abrupt elevations of blood pressure, renal decompensation, fluid retention, and immunosuppressive therapy. We report three children with reversible posterior leukoencephalopathy syndrome presenting with generalized seizures and headache. The causes of reversible posterior leukoencephalopathy syndrome were considered to be acute hypertension and immunosuppressive therapy in case 1 with systemic lupus erythematosus, chemotherapy (vincristine and/or actinomycin-D) and hyponatremia in case 2, and acute hypertension in case 3, admitted with a familial Mediterranean fever attack. In light of these cases, we review the literature for the etiology, clinical and laboratory findings, and pathogenetic mechanisms of the disease. ( J Child Neurol 2005;12:990—993).

Get full access to this article

View all access options for this article.

References

Hinchey J. , Chaves C. , Appignani B. , et al: A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494—500.

Kwon S. , Koo J. , Lee S. : Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol 2001; 24: 361—364.

Laguna P. , Martin T. , Marchena MJ , Moya M. : Posterior leukoencephalopathy reversible syndrome secondary to panarteritis nodosa. Med Clin (Barc) 1997;109:397—398.

Gimenez-Mesa E. , Martinez-Salio A. , Porta-Etessam J. , et al: Reversible posterior leukoencephalopathy in a patient with non-Hodgkin's lymphoma after treatment with CHOP. An Med Interna 2001;18:591—593.

Edwards MJ , Walker R. , Vinnicombe S. , et al: Reversible posterior leukoencephalopathy syndrome following CHOP chemotherapy for diffuse large B-cell lymphoma. Ann Oncol 2001;12:1327—1329.

Ito Y. , Niwa H. , Iida T. , et al: Post-transfusion reversible posterior leukoencephalopathy syndrome with cerebral vasoconstriction. Neurology 1997;49:1174—1175.

Mathy I. , Gille M. , van Raemdonck F. , et al: Neurological complications of intravenous immunoglobulin (IVIg) therapy: An illustrative case of acute encephalopathy following IVIg therapy and a review of the literature. Acta Neurol Belg 1998;98:347-351

Delanty N. , Vaughan C. , Frucht S. , Stubgen P. : Erythropoietin-associated hypertensive posterior leukoencephalopathy. Neurology 1997;49:686—689.

Pavlakis SG , Frank Y. , Chusid R. : Hypertensive encephalopathy, reversible occipitoparietal encephalopathy, or reversible posterior leukoencephalopathy: Three names for an old syndrome . J Child Neurol 1999;14:277—281.

10.

Antunes NL , Small TN , George D. , et al: Posterior leukoencephalopathy syndrome may not be reversible . Pediatr Neurol 1999;20:241—243.

11.

Cooney MJ , Bradley WG , Symko SC , et al: Hypertensive encephalopathy: Complication in children treated for myeloproliferative disorders—Report of three cases. Radiology 2000;214:711—716.

12.

Pavlakis SG , Frank Y. , Kalina P. , et al: Occipital-parietal encephalopathy: A new name for an old syndrome. Pediatr Neurol 1997; 16:145—148.

13.

Ay H. , Buonanno FS , Schaefer PW , et al: Posterior leukoencephalopathy without severe hypertension: Utility of diffusion-weighted MRI. Neurology 1998;51:1369—1376.

14.

Schwartz RB , Jones KM , Kalina P. , et al: Hypertensive encephalopathy: Findings on CT, MR imaging and SPECT imaging in 14 cases. AJR Am J Roentgenol 1992;159:379—383.

15.

Pace MT , Slovis TL , Kelly JK , Abella SD : Cyclosporin A toxicity: MRI appearance of the brain. Pediatr Radiol 1995; 25: 180—183.

16.

Schwartz RB , Bravo SM , Klufas RA , et al: Cyclosporine neuro-toxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases . AJR Am J Roentgenol 1995;165:627—631.

17.

Johansson BB : The blood brain barrier and cerebral blood flow in acute hypertension. Acta Med Scand (Suppl) 1983;678:107—112.

18.

Schaefer PW , Buonanno FS , Gonzales RG , Schwamm LH : Diffusion-weighted imaging discriminated between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 1997;28:1082—1085.

19.

Sundt T. : The cerebral autonomic nervous system: A proposed physiologic function and pathophysiologic response in subarachnoid hemorrhage and in focal cerebral ischemia. Mayo Clin Proc 1973;48:127—137.

20.

Sommer BG , Henry ML , Ferguson RM : Cyclosporine-associated renal arteriopathy. Transplant Proc 1986;18:151—157.

21.

Brown Z. , Neild GH : Cyclosporine inhibits prostacyclin production by cultured human endothelial cells. Transplant Proc 1987;19:1178—1180.

22.

Jarosz JM , Howlett DC , Cox TC , Bingham JB : Cyclosporine-related reversible posterior leukoencephalopathy: MRI. Neuroradiology 1997;39:711—715.

23.

Eichler FS , Wang P. , Wityk RJ , et al: Diffuse metabolic abnormalities in reversible posterior leukoencephalopathy syndrome. AJNR Am J Neuroradiol 2002;23:833—837.